FDX:NYSEFedEx Corporation Analysis
Data as of 2026-09-01 - not real-time
$319.86
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
At $319.86, FedEx Corporation shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 1.5%. Relative strength is 44.7 — neutral — and the MACD signal is bearish. Price has been bracketed by support at $309.07 and resistance at $341.69.
Multiples put this in undervalued territory: 17.2 times earnings against the sector's 28.6. Consensus targets land 11.4% above where the shares trade now. Revenue is growing at 12.5% on a 4.7% profit margin. The 1.49% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 22.4%, a beta of 0.90 and a maximum drawdown of 12.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.
Multiples put this in undervalued territory: 17.2 times earnings against the sector's 28.6. Consensus targets land 11.4% above where the shares trade now. Revenue is growing at 12.5% on a 4.7% profit margin. The 1.49% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 22.4%, a beta of 0.90 and a maximum drawdown of 12.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.
Top Market Events
Seeking Alpha14dThe European Commission approves FedEx-led consortium to acquire InPostThe European Commission...FedEx stock traded in the mid-$330s on August 26, 2026, as investors weigh a strong year-to-date ralSeeking Alpha25dFedEx: Premium Revenue Mix And Network Transformation Support A BuyFedEx is pivoting to premium B2B,...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 290.03
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 17.2 versus sector average of 28.6
- Trading above the 200-day average of 290.03
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 17.2 versus sector average of 28.6
- Analyst targets imply +11.4% versus the current price
- Revenue growth of +12.5%
Key Metrics & Analysis
Financial Health
Revenue Growth12.50%
Profit Margin4.68%
P/E Ratio17.2
ROE14.85%
ROA5.01%
Debt/Equity135.70
P/B Ratio2.4
Op. Cash Flow$8.9B
Free Cash Flow$5.7B
Industry P/E28.6
Technical Analysis
TrendBullish
RSI44.7
Support$309.07
Resistance$341.69
MA 20$327.30
MA 50$319.34
MA 200$290.03
MACDBearish
VolumeDecreasing
Fear & Greed Index92.43
Valuation
Fair Value$388.50
Target Price$356.37
Upside/Downside11.41%
GradeUndervalued
TypeBlend
Dividend Yield1.49%
Risk Assessment
Beta0.90
Volatility22.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.